STOK Stoke Therapeutics, Inc.
Healthcare · Pharmaceutical Preparations · Market cap: $1.7B
–
Bought and sold by quarter, last 5 years
Open-market purchases and sales by this company's insiders, in dollars, last 5 years
| Quarter | Bought | Sold |
|---|---|---|
| 2022-Q1 | $0 | $87.7K |
| 2022-Q2 | $0 | $0 |
| 2022-Q3 | $0 | $0 |
| 2022-Q4 | $0 | $0 |
| 2023-Q1 | $0 | $192.1K |
| 2023-Q2 | $0 | $755.0K |
| 2023-Q3 | $0 | $159.0K |
| 2023-Q4 | $0 | $0 |
| 2024-Q1 | $0 | $408.2K |
| 2024-Q2 | $0 | $44.5M |
| 2024-Q3 | $0 | $27.7M |
| 2024-Q4 | $0 | $24.1M |
| 2025-Q1 | $0 | $260.6K |
| 2025-Q2 | $0 | $30.9M |
| 2025-Q3 | $0 | $2.4M |
| 2025-Q4 | $0 | $6.5M |
| 2026-Q1 | $0 | $3.1M |
| 2026-Q2 | $0 | $232.1K |
| 2026-Q3 | $0 | $1.3M |
| 2026-Q4 | $0 | $233.9K |
Bought$00 buy days
Sold$142.9M118 sell days
Net insider flow-$142.9Mnet selling · 5 years
Latest trade2026-11-02Ticho Barry
| Date | Side | Insider | Role | Shares | Avg price | Value | Trades |
|---|---|---|---|---|---|---|---|
| 2026-11-02 | Sell | Ticho Barry | Other C-suite | 7,195 | $26.39 | $189.9K | 2 |
| 2026-10-02 | Sell | Allan Jonathan | General counsel | 627 | $26.33 | $16.5K | 1 |
| 2026-10-01 | Sell | Ticho Barry | Other C-suite | 1,051 | $26.16 | $27.5K | 1 |
| 2026-09-01 | Sell | Ticho Barry | Other C-suite | 5,545 | $30.67 | $170.1K | 2 |
| 2026-08-18 | Sell | Kaye Edward M. MD | Director | 12,567 | $32.03 | $402.5K | 2 |
| 2026-08-18 | Sell | Ticho Barry | Other C-suite | 4,767 | $32.03 | $152.7K | 2 |
| 2026-08-18 | Sell | Allan Jonathan | General counsel | 2,861 | $32.03 | $91.6K | 2 |
| 2026-08-03 | Sell | Ticho Barry | Other C-suite | 7,176 | $29.04 | $208.4K | 2 |
| 2026-07-01 | Sell | Ticho Barry | Other C-suite | 7,228 | $32.66 | $236.1K | 2 |
| 2026-06-16 | Sell | Allan Jonathan | General counsel | 1,457 | $29.95 | $43.6K | 1 |
| 2026-06-01 | Sell | Ticho Barry | Other C-suite | 1,795 | $30.58 | $54.9K | 1 |
| 2026-05-01 | Sell | Ticho Barry | Other C-suite | 2,243 | $32.79 | $73.5K | 1 |
| 2026-04-01 | Sell | Ticho Barry | Other C-suite | 1,838 | $32.66 | $60.0K | 1 |
| 2026-03-20 | Sell | Allan Jonathan | General counsel | 9,293 | $33.69 | $313.1K | 2 |
| 2026-03-19 | Sell | Ticho Barry | Other C-suite | 1,461 | $29.99 | $43.8K | 1 |
| 2026-03-18 | Sell | Ticho Barry | Other C-suite | 6,686 | $31.34 | $209.5K | 3 |
| 2026-03-18 | Sell | Allan Jonathan | General counsel | 4,628 | $31.34 | $145.0K | 3 |
| 2026-03-18 | Sell | Leggett Thomas | CFO | 2,382 | $31.34 | $74.7K | 3 |
| 2026-03-18 | Sell | Hoitt Jason | Other C-suite | 1,931 | $31.34 | $60.5K | 3 |
| 2026-03-17 | Sell | Ticho Barry | Other C-suite | 6,164 | $33.01 | $203.5K | 2 |
| 2026-03-17 | Sell | Allan Jonathan | General counsel | 4,267 | $33.01 | $140.8K | 2 |
| 2026-03-17 | Sell | Leggett Thomas | CFO | 2,196 | $33.01 | $72.5K | 2 |
| 2026-03-17 | Sell | Hoitt Jason | Other C-suite | 1,781 | $33.01 | $58.8K | 2 |
| 2026-03-13 | Sell | LEVIN ARTHUR A | Director | 605 | $36.80 | $22.3K | 1 |
| 2026-03-10 | Sell | Krainer Adrian R. | Director | 33,243 | $39.74 | $1.3M | 1 |
| 2026-03-10 | Sell | TZIANABOS ARTHUR | Chair | 4,355 | $40.00 | $174.2K | 1 |
| 2026-03-02 | Sell | Krainer Adrian R. | Director | 7,229 | $39.66 | $286.7K | 1 |
| 2025-12-08 | Sell | Kaye Edward M. MD | Director | 13,430 | $32.27 | $433.4K | 3 |
| 2025-12-08 | Sell | Allan Jonathan | General counsel | 3,978 | $32.28 | $128.4K | 2 |
| 2025-12-05 | Sell | Allan Jonathan | General counsel | 8,785 | $31.29 | $274.9K | 3 |
| 2025-12-05 | Sell | Kaye Edward M. MD | Director | 8,548 | $31.33 | $267.8K | 3 |
| 2025-12-05 | Sell | Ticho Barry | Other C-suite | 3,662 | $31.34 | $114.8K | 2 |
| 2025-12-04 | Sell | Kaye Edward M. MD | Director | 6,453 | $30.87 | $199.2K | 2 |
| 2025-12-04 | Sell | Ticho Barry | Other C-suite | 1,696 | $30.87 | $52.3K | 2 |
| 2025-12-04 | Sell | Allan Jonathan | General counsel | 1,018 | $30.87 | $31.4K | 2 |
| 2025-12-03 | Sell | Allan Jonathan | General counsel | 2,292 | $30.65 | $70.3K | 2 |
| 2025-12-03 | Sell | Ticho Barry | Other C-suite | 2,014 | $30.65 | $61.7K | 2 |
| 2025-12-03 | Sell | Kaye Edward M. MD | Director | 1,070 | $30.65 | $32.8K | 2 |
| 2025-12-02 | Sell | Allan Jonathan | General counsel | 2,284 | $29.78 | $68.0K | 2 |
| 2025-12-02 | Sell | Ticho Barry | Other C-suite | 2,006 | $29.78 | $59.7K | 2 |
| 2025-12-02 | Sell | Kaye Edward M. MD | Director | 1,066 | $29.78 | $31.7K | 2 |
| 2025-11-24 | Sell | Krainer Adrian R. | Director | 40,472 | $29.72 | $1.2M | 1 |
| 2025-11-14 | Sell | Krainer Adrian R. | Director | 40,472 | $26.98 | $1.1M | 2 |
| 2025-11-03 | Sell | Ticho Barry | Other C-suite | 5,931 | $25.72 | $152.5K | 4 |
| 2025-10-08 | Sell | Kaye Edward M. MD | Director | 25,000 | $30.00 | $750.0K | 1 |
| 2025-10-03 | Sell | Kaye Edward M. MD | Director | 42,461 | $25.09 | $1.1M | 1 |
| 2025-10-03 | Sell | Allan Jonathan | General counsel | 10,000 | $25.07 | $250.7K | 1 |
| 2025-10-01 | Sell | Ticho Barry | Other C-suite | 5,343 | $23.64 | $126.3K | 1 |
| 2025-09-03 | Sell | Kaye Edward M. MD | Director | 45,996 | $20.13 | $925.9K | 1 |
| 2025-09-03 | Sell | Allan Jonathan | General counsel | 6,345 | $20.07 | $127.3K | 1 |
| 2025-09-02 | Sell | Allan Jonathan | General counsel | 14,922 | $20.14 | $300.5K | 1 |
| 2025-09-02 | Sell | Kaye Edward M. MD | Director | 14,860 | $20.14 | $299.3K | 1 |
| 2025-09-02 | Sell | Ticho Barry | Other C-suite | 5,501 | $19.87 | $109.3K | 1 |
| 2025-08-29 | Sell | Kaye Edward M. MD | Director | 1,029 | $20.00 | $20.6K | 1 |
| 2025-08-29 | Sell | Allan Jonathan | General counsel | 850 | $20.00 | $17.0K | 1 |
| 2025-08-18 | Sell | Kaye Edward M. MD | Director | 12,126 | $18.24 | $221.2K | 1 |
| 2025-08-18 | Sell | Ticho Barry | Other C-suite | 2,805 | $18.24 | $51.2K | 1 |
| 2025-08-18 | Sell | Allan Jonathan | General counsel | 1,683 | $18.24 | $30.7K | 1 |
| 2025-08-13 | Sell | Allan Jonathan | General counsel | 13,712 | $15.00 | $205.7K | 1 |
| 2025-08-01 | Sell | Ticho Barry | Other C-suite | 4,504 | $12.82 | $57.7K | 1 |
| 2025-07-01 | Sell | Ticho Barry | Other C-suite | 4,503 | $11.63 | $52.4K | 1 |
| 2025-06-04 | Sell | Ezbon International Ltd | 10% owner | 3,000,000 | $10.20 | $30.6M | 1 |
| 2025-06-03 | Sell | Ticho Barry | Other C-suite | 6,471 | $10.03 | $64.9K | 1 |
| 2025-06-02 | Sell | Ticho Barry | Other C-suite | 1,745 | $10.00 | $17.4K | 1 |
| 2025-05-02 | Sell | Ticho Barry | Other C-suite | 22,790 | $10.03 | $228.6K | 1 |
| 2025-05-01 | Sell | Ticho Barry | Other C-suite | 3,841 | $10.00 | $38.4K | 1 |
| 2025-03-19 | Sell | Kaye Edward M. MD | Director | 8,907 | $8.27 | $73.7K | 1 |
| 2025-03-19 | Sell | Ticho Barry | Other C-suite | 3,333 | $8.27 | $27.6K | 1 |
| 2025-03-19 | Sell | Allan Jonathan | General counsel | 1,945 | $8.27 | $16.1K | 1 |
| 2025-03-18 | Sell | Kaye Edward M. MD | Director | 10,382 | $8.67 | $90.0K | 1 |
| 2025-03-18 | Sell | Ticho Barry | Other C-suite | 3,884 | $8.67 | $33.7K | 1 |
| 2025-03-18 | Sell | Allan Jonathan | General counsel | 2,266 | $8.67 | $19.6K | 1 |
| 2024-12-23 | Sell | Ezbon International Ltd | 10% owner | 2,000,000 | $11.50 | $23.0M | 1 |
| 2024-12-09 | Sell | Allan Jonathan | General counsel | 13,666 | $13.61 | $186.0K | 2 |
| 2024-12-09 | Sell | Kaye Edward M. MD | CEO | 6,786 | $12.99 | $88.2K | 1 |
| 2024-12-09 | Sell | Ticho Barry | Other C-suite | 2,586 | $12.99 | $33.6K | 1 |
| 2024-12-06 | Sell | Ticho Barry | Other C-suite | 13,945 | $12.78 | $178.2K | 1 |
| 2024-12-06 | Sell | Allan Jonathan | General counsel | 9,696 | $12.78 | $123.9K | 1 |
| 2024-12-06 | Sell | Kaye Edward M. MD | CEO | 6,170 | $12.78 | $78.9K | 1 |
| 2024-12-02 | Sell | Ticho Barry | Other C-suite | 10,000 | $12.07 | $120.7K | 1 |
| 2024-11-01 | Sell | Ticho Barry | Other C-suite | 10,000 | $12.68 | $126.8K | 1 |
| 2024-10-01 | Sell | Ticho Barry | Other C-suite | 10,000 | $12.06 | $120.6K | 1 |
| 2024-09-19 | Sell | Ezbon International Ltd | 10% owner | 1,937,500 | $14.05 | $27.2M | 1 |
| 2024-09-03 | Sell | Ticho Barry | Other C-suite | 10,000 | $14.95 | $149.5K | 2 |
| 2024-08-01 | Sell | Ticho Barry | Other C-suite | 10,000 | $14.58 | $145.8K | 1 |
| 2024-07-02 | Sell | Nash Huw M. | Other C-suite | 2,500 | $13.11 | $32.8K | 2 |
| 2024-07-01 | Sell | Ticho Barry | Other C-suite | 10,000 | $13.75 | $137.5K | 1 |
| 2024-06-03 | Sell | Ticho Barry | Other C-suite | 10,000 | $15.22 | $152.2K | 2 |
| 2024-05-20 | Sell | Nash Huw M. | COO | 50,000 | $15.39 | $769.5K | 1 |
| 2024-05-20 | Sell | Kaye Edward M. MD | CEO | 42,350 | $15.43 | $653.5K | 2 |
| 2024-05-20 | Sell | Allan Jonathan | General counsel | 8,599 | $15.04 | $129.3K | 1 |
| 2024-05-01 | Sell | Ticho Barry | Other C-suite | 10,000 | $11.37 | $113.7K | 1 |
| 2024-04-17 | Sell | Ezbon International Ltd | 10% owner | 3,600,000 | $11.60 | $41.8M | 1 |
| 2024-04-01 | Sell | Nash Huw M. | COO | 61,329 | $13.22 | $810.9K | 2 |
| 2024-04-01 | Sell | Ticho Barry | Other C-suite | 9,426 | $13.23 | $124.7K | 1 |
| 2024-03-28 | Sell | Allan Jonathan | General counsel | 5,126 | $13.20 | $67.7K | 2 |
| 2024-03-19 | Sell | Kaye Edward M. MD | CEO | 11,150 | $6.10 | $68.0K | 1 |
| 2024-03-19 | Sell | Ticho Barry | Other C-suite | 4,116 | $6.10 | $25.1K | 1 |
| 2024-03-19 | Sell | Nash Huw M. | COO | 4,116 | $6.10 | $25.1K | 1 |
| 2024-03-19 | Sell | Tulipano Stephen J | CFO | 4,116 | $6.10 | $25.1K | 1 |
| 2024-03-19 | Sell | Allan Jonathan | General counsel | 2,349 | $6.10 | $14.3K | 1 |
| 2024-03-01 | Sell | Ticho Barry | Other C-suite | 10,000 | $7.75 | $77.5K | 1 |
| 2024-02-01 | Sell | Ticho Barry | Other C-suite | 10,000 | $4.80 | $48.0K | 1 |
| 2024-01-02 | Sell | Ticho Barry | Other C-suite | 10,000 | $5.74 | $57.4K | 1 |
| 2023-07-03 | Sell | Ticho Barry | Other C-suite | 15,000 | $10.60 | $159.0K | 1 |
| 2023-06-21 | Sell | Allan Jonathan | General counsel | 1,948 | $13.48 | $26.3K | 1 |
| 2023-06-01 | Sell | Ticho Barry | Other C-suite | 15,000 | $11.13 | $167.0K | 1 |
| 2023-05-04 | Sell | Ticho Barry | Other C-suite | 653 | $10.00 | $6.5K | 1 |
| 2023-05-03 | Sell | Ticho Barry | Other C-suite | 24,697 | $10.14 | $250.4K | 1 |
| 2023-05-02 | Sell | Ticho Barry | Other C-suite | 5,513 | $10.00 | $55.1K | 1 |
| 2023-05-01 | Sell | Ticho Barry | Other C-suite | 24,967 | $10.00 | $249.7K | 1 |
| 2023-02-06 | Sell | Ticho Barry | Other C-suite | 9,235 | $10.02 | $92.5K | 1 |
| 2023-02-03 | Sell | Ticho Barry | Other C-suite | 3,763 | $10.03 | $37.7K | 1 |
| 2023-02-02 | Sell | Ticho Barry | Other C-suite | 267 | $10.00 | $2.7K | 1 |
| 2023-02-01 | Sell | Ticho Barry | Other C-suite | 5,705 | $10.02 | $57.2K | 1 |
| 2023-01-31 | Sell | Ticho Barry | Other C-suite | 200 | $10.00 | $2.0K | 1 |
| 2022-01-03 | Sell | Nash Huw M. | COO | 3,800 | $23.07 | $87.7K | 3 |
| 2021-12-01 | Sell | Nash Huw M. | COO | 5,700 | $24.44 | $139.3K | 2 |
Who the insiders are, last 5 years
Everyone who bought or sold this company's shares on the open market in the last 5 years, biggest first.
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| Ezbon International Ltd | 10% owner | $0 | $122.6M | 2025-06-04 |
| Kaye Edward M. MD | Director | $0 | $5.7M | 2026-08-18 |
| Ticho Barry | Other C-suite | $0 | $5.6M | 2026-11-02 |
| Krainer Adrian R. | Director | $0 | $3.9M | 2026-03-10 |
| Allan Jonathan | General counsel | $0 | $2.8M | 2026-10-02 |
| Nash Huw M. | Other C-suite | $0 | $1.9M | 2024-07-02 |
| TZIANABOS ARTHUR | Chair | $0 | $174.2K | 2026-03-10 |
| Leggett Thomas | CFO | $0 | $147.1K | 2026-03-18 |
| Hoitt Jason | Other C-suite | $0 | $119.3K | 2026-03-18 |
| Tulipano Stephen J | CFO | $0 | $25.1K | 2024-03-19 |
| LEVIN ARTHUR A | Director | $0 | $22.3K | 2026-03-13 |
Past buying clusters
A cluster is a run of purchases by three or more insiders. Returns are the stock's return minus its benchmark's (IWM for small companies, SPY otherwise), from the first open after the run became a cluster. Past results, not a forecast.
| Window | Insiders | Total | Score | 21 days vs benchmark | 63 days vs benchmark | 126 days vs benchmark | Status |
|---|---|---|---|---|---|---|---|
| 2019-06-19 → 2019-06-21 | 3 | $60.0M | 44 | -9.5% (-7.0% raw) | -17.1% (-15.5% raw) | -4.1% (+6.1% raw) | closed |
Yahoo Finance data, delayed, loaded through this server. Informational only; not investment advice.